The City of Macaé announced that the 1st seminar on medical cannabis will be held in the municipality. The medical use of cannabis-based products has been under discussion in Brazil for some time now. With the regulation of Anvisa, the questions about cannabis benefits on health, criteria and use have gained more strength and the need for clarification as well.
The event will be open to the general public, legal and physiological aspects of the medicinal cannabis use will be addressed by experts, in addition to the opportunity for a discussion table.
With the recent regulation of the National Health Surveillance Agency (Anvisa) for the manufacture, import, and marketing of cannabis-derived medicines, questions about the benefits, criteria, and use of the cannabis plant extract have gained more strength and need for clarification.
The Hemp.im application is the world’s marijuana source to learn about this emerging industry. Millions of people use our mobile application to discover and find the latest hemp news.
The 1st medical cannabis seminar
It is with this objective in mind that the City Hall of Macaé, through the Municipal Health Secretariat, in partnership with the Brazilian Cannabis Association (ABRA Cannabis), will promote the 1st Seminar on Medical Cannabis in the municipality.
The meetings will be held at the Roberto Marinho Convention Center, on March, 14th and March, 15th, from 9 am to 5 pm. The legal and physiological aspects of the medical use of cannabis will be addressed by experts, as well as the opportunity to open debates.
Discussion on medical cannabis benefits
The representative of ABRA Cannabis, Vinicius Pereira, pointed out that discussing and broadening the approach to the subject is fundamental so that more people can enjoy the medical benefits of cannabis extract.
“Meetings like this one that will be held in Macaé are being held all over Brazil, so that more people can get to know and be benefited, improving their health and quality of life,” he said.
Cannabis extract that was created in Macaé
Denise Mello, mother of a 4-year-old girl, who was born with microcephaly and currently uses the extract to treat intracranial epilepsies, is in charge of the organization Rede do Bem, which is being created in Macaé. She claimed that the results were impressive and that in just one and a half months of use, her daughter’s epilepsies decreased by 20%. “We are talking about something that is bringing more dignity to people’s lives and that needs to be de-stigmatized,” she stressed.
The event will be open to the general public, from patients to health professionals. The Convention Center is located at Rodovia Amaral Peixoto, km 181, São José do Barreto. On March, 14th, on Saturday, there is a presentation on the theme and soon after the Doctor in Psychology by UERJ, Lauro Pontes talks about the history of marijuana and psychosocial issues.
The medical aspects will be presented by Dr. Eduardo Faveret, pediatric neurologist and Coordinator of the Epilepsy Center of the State Institute of Brain Paulo Niemeyer. From 3 pm there will be debates and questions, and then a lecture on cultivation techniques in small spaces with Bernardo Monteiro. On Sunday (March, 16th), themes such as physiology, botany and cultivation techniques will be discussed by Pedro Zarur and Daniel Zarur. There will also be a talk about pests and other agricultural issues and legal aspects.
Among the specialists who will attend the event will be the doctor in psychology from the State University of Rio de Janeiro (UERJ), Dr. Lauro Pontes; the criminal lawyer in the Legal Network for Drug Policy Reform, Marcela Goldschimt; the pediatric neurologist and coordinator of the Epilepsy Center of the State Institute of Brain Paulo Niemayer, Dr. Eduardo Faveret; besides Pedrão Zarur and Daniel Zarur, who will talk about physiology, botany, and cannabis cultivation techniques; Dennys Zsolt, who will discuss pests and other agricultural issues; and Bernardo Monteiro, who will present protected cultivation techniques.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in SFn, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.